Preclinical Experimental and Mathematical Approaches for Assessing Effective Doses of Inhaled Drugs, Using Mometasone to Support Human Dose Predictions-Reference-Cited by-同舟云学术

Preclinical Experimental and Mathematical Approaches for Assessing Effective Doses of Inhaled Drugs, Using Mometasone to Support Human Dose Predictions

Published:2016-08 Issue:4 Volume:29 Page:362-377
ISSN:1941-2711
Container-title:Journal of Aerosol Medicine and Pulmonary Drug Delivery
language:en
Short-container-title:Journal of Aerosol Medicine and Pulmonary Drug Delivery

Author:

Caniga Michael¹,Cabal Antonio²,Mehta Khamir²,Ross David S.³,Gil Malgorzata A.¹,Woodhouse Janice D.¹,Eckman Joseph¹,Naber John R.⁴,Callahan Marissa K.⁴,Goncalves Luciano²,Hill Susan E.²,Mcleod Robbie L.¹,McIntosh Fraser⁵,Freke Mark C.⁵,Visser Sandra A.G.²,Johnson Neil⁶,Salmon Michael⁷,Cicmil Milenko¹

Affiliation:

1. Department of Pharmacology, Merck Research Laboratories, Boston, Massachusetts, and West Point, Pennsylvania.

2. Department of Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Merck Research Laboratories, Boston, Massachusetts, and West Point, Pennsylvania.

3. Center for Applied and Computational Mathematics, Rochester Institute of Technology, Rochester, New York.

4. Department of Discovery Pharmaceutical Sciences, Merck Research Laboratories, Boston, Massachusetts, and West Point, Pennsylvania.

5. Discovery Research Services Charles River Laboratories, Senneville, Quebec, Canada.

6. Department of Safety Assessment and Laboratory Animal Sciences, Merck Research Laboratories, Boston, Massachusetts, and West Point, Pennsylvania.

7. Department of Biology Discovery, Merck Research Laboratories, Boston, Massachusetts, and West Point, Pennsylvania.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmaceutical Science,Pulmonary and Respiratory Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/jamp.2015.1253

Reference38 articles.

1. Epidemiology and Prevalence of Chronic Obstructive Pulmonary Disease

2. The increasing challenge of discovering asthma drugs

3. Optimisation of DMPK by the Inhaled Route: Challenges and Approaches

4. INFECTIONS ASSOCIATED WITH STEROID USE

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Designing inhaled small molecule drugs for severe respiratory diseases: an overview of the challenges and opportunities;Expert Opinion on Drug Discovery;2024-02-26

2. iBCS: 2. Mechanistic Modeling of Pulmonary Availability of Inhaled Drugs versus Critical Product Attributes;Molecular Pharmaceutics;2022-05-24

3. Predicting systemic and pulmonary tissue barrier concentration of orally inhaled drug products;2022-03-12

4. Assessment of the predictive capability of modelling and simulation to determine bioequivalence of inhaled drugs: A systematic review;DARU Journal of Pharmaceutical Sciences;2022-01-30

5. Physiologically-based pharmacokinetic modeling after drug inhalation;Inhaled Medicines;2021